Copyright Reports & Markets. All rights reserved.

Global and Japan Pressurized Metered-dose Inhaler Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Pressurized Metered-dose Inhaler Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Pressurized Metered-dose Inhaler Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Pressurized Metered-dose Inhaler Market Size Growth Rate by Type
    • 1.4.2 Single-dose Inhalers
    • 1.4.3 Multi-dose Inhalers
  • 1.5 Market by Application
    • 1.5.1 Global Pressurized Metered-dose Inhaler Market Size Growth Rate by Application
    • 1.5.2 Hospitals
    • 1.5.3 Ambulatory Surgery Centres
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Pressurized Metered-dose Inhaler Market Size, Estimates and Forecasts
    • 2.1.1 Global Pressurized Metered-dose Inhaler Revenue 2015-2026
    • 2.1.2 Global Pressurized Metered-dose Inhaler Sales 2015-2026
  • 2.2 Global Pressurized Metered-dose Inhaler, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Pressurized Metered-dose Inhaler Historical Market Size by Region (2015-2020)
    • 2.3.1 Global Pressurized Metered-dose Inhaler Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global Pressurized Metered-dose Inhaler Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 Pressurized Metered-dose Inhaler Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Pressurized Metered-dose Inhaler Sales Forecast by Region (2021-2026)
    • 2.4.2 Global Pressurized Metered-dose Inhaler Revenue Forecast by Region (2021-2026)

3 Global Pressurized Metered-dose Inhaler Competitor Landscape by Players

  • 3.1 Global Top Pressurized Metered-dose Inhaler Sales by Manufacturers
    • 3.1.1 Global Pressurized Metered-dose Inhaler Sales by Manufacturers (2015-2020)
    • 3.1.2 Global Pressurized Metered-dose Inhaler Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global Pressurized Metered-dose Inhaler Manufacturers by Revenue
    • 3.2.1 Global Pressurized Metered-dose Inhaler Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global Pressurized Metered-dose Inhaler Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Pressurized Metered-dose Inhaler Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Pressurized Metered-dose Inhaler Revenue in 2019
    • 3.2.5 Global Pressurized Metered-dose Inhaler Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global Pressurized Metered-dose Inhaler Price by Manufacturers
  • 3.4 Global Pressurized Metered-dose Inhaler Manufacturing Base Distribution, Product Types
    • 3.4.1 Pressurized Metered-dose Inhaler Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Pressurized Metered-dose Inhaler Product Type
    • 3.4.3 Date of International Manufacturers Enter into Pressurized Metered-dose Inhaler Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Pressurized Metered-dose Inhaler Market Size by Type (2015-2020)
    • 4.1.1 Global Pressurized Metered-dose Inhaler Sales by Type (2015-2020)
    • 4.1.2 Global Pressurized Metered-dose Inhaler Revenue by Type (2015-2020)
    • 4.1.3 Pressurized Metered-dose Inhaler Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Pressurized Metered-dose Inhaler Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Pressurized Metered-dose Inhaler Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Pressurized Metered-dose Inhaler Revenue Forecast by Type (2021-2026)
    • 4.2.3 Pressurized Metered-dose Inhaler Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Pressurized Metered-dose Inhaler Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Pressurized Metered-dose Inhaler Market Size by Application (2015-2020)
    • 5.1.1 Global Pressurized Metered-dose Inhaler Sales by Application (2015-2020)
    • 5.1.2 Global Pressurized Metered-dose Inhaler Revenue by Application (2015-2020)
    • 5.1.3 Pressurized Metered-dose Inhaler Price by Application (2015-2020)
  • 5.2 Pressurized Metered-dose Inhaler Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Pressurized Metered-dose Inhaler Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Pressurized Metered-dose Inhaler Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Pressurized Metered-dose Inhaler Price Forecast by Application (2021-2026)

6 Japan by Players, Type and Application

  • 6.1 Japan Pressurized Metered-dose Inhaler Market Size YoY Growth 2015-2026
    • 6.1.1 Japan Pressurized Metered-dose Inhaler Sales YoY Growth 2015-2026
    • 6.1.2 Japan Pressurized Metered-dose Inhaler Revenue YoY Growth 2015-2026
    • 6.1.3 Japan Pressurized Metered-dose Inhaler Market Share in Global Market 2015-2026
  • 6.2 Japan Pressurized Metered-dose Inhaler Market Size by Players (International and Local Players)
    • 6.2.1 Japan Top Pressurized Metered-dose Inhaler Players by Sales (2015-2020)
    • 6.2.2 Japan Top Pressurized Metered-dose Inhaler Players by Revenue (2015-2020)
  • 6.3 Japan Pressurized Metered-dose Inhaler Historic Market Review by Type (2015-2020)
    • 6.3.1 Japan Pressurized Metered-dose Inhaler Sales Market Share by Type (2015-2020)
    • 6.3.2 Japan Pressurized Metered-dose Inhaler Revenue Market Share by Type (2015-2020)
    • 6.3.3 Japan Pressurized Metered-dose Inhaler Price by Type (2015-2020)
  • 6.4 Japan Pressurized Metered-dose Inhaler Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 Japan Pressurized Metered-dose Inhaler Sales Forecast by Type (2021-2026)
    • 6.4.2 Japan Pressurized Metered-dose Inhaler Revenue Forecast by Type (2021-2026)
    • 6.4.3 Japan Pressurized Metered-dose Inhaler Price Forecast by Type (2021-2026)
  • 6.5 Japan Pressurized Metered-dose Inhaler Historic Market Review by Application (2015-2020)
    • 6.5.1 Japan Pressurized Metered-dose Inhaler Sales Market Share by Application (2015-2020)
    • 6.5.2 Japan Pressurized Metered-dose Inhaler Revenue Market Share by Application (2015-2020)
    • 6.5.3 Japan Pressurized Metered-dose Inhaler Price by Application (2015-2020)
  • 6.6 Japan Pressurized Metered-dose Inhaler Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 Japan Pressurized Metered-dose Inhaler Sales Forecast by Application (2021-2026)
    • 6.6.2 Japan Pressurized Metered-dose Inhaler Revenue Forecast by Application (2021-2026)
    • 6.6.3 Japan Pressurized Metered-dose Inhaler Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America Pressurized Metered-dose Inhaler Market Size YoY Growth 2015-2026
  • 7.2 North America Pressurized Metered-dose Inhaler Market Facts & Figures by Country
    • 7.2.1 North America Pressurized Metered-dose Inhaler Sales by Country (2015-2020)
    • 7.2.2 North America Pressurized Metered-dose Inhaler Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe Pressurized Metered-dose Inhaler Market Size YoY Growth 2015-2026
  • 8.2 Europe Pressurized Metered-dose Inhaler Market Facts & Figures by Country
    • 8.2.1 Europe Pressurized Metered-dose Inhaler Sales by Country
    • 8.2.2 Europe Pressurized Metered-dose Inhaler Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Pressurized Metered-dose Inhaler Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific Pressurized Metered-dose Inhaler Market Facts & Figures by Country
    • 9.2.1 Asia Pacific Pressurized Metered-dose Inhaler Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific Pressurized Metered-dose Inhaler Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America Pressurized Metered-dose Inhaler Market Size YoY Growth 2015-2026
  • 10.2 Latin America Pressurized Metered-dose Inhaler Market Facts & Figures by Country
    • 10.2.1 Latin America Pressurized Metered-dose Inhaler Sales by Country
    • 10.2.2 Latin America Pressurized Metered-dose Inhaler Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Pressurized Metered-dose Inhaler Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Pressurized Metered-dose Inhaler Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Pressurized Metered-dose Inhaler Sales by Country
    • 11.2.2 Middle East and Africa Pressurized Metered-dose Inhaler Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 U.A.E

12 Company Profiles

  • 12.1 Glenmark Pharmaceuticals (India)
    • 12.1.1 Glenmark Pharmaceuticals (India) Corporation Information
    • 12.1.2 Glenmark Pharmaceuticals (India) Description and Business Overview
    • 12.1.3 Glenmark Pharmaceuticals (India) Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 Glenmark Pharmaceuticals (India) Pressurized Metered-dose Inhaler Products Offered
    • 12.1.5 Glenmark Pharmaceuticals (India) Recent Development
  • 12.2 Novartis International AG (Switzerland)
    • 12.2.1 Novartis International AG (Switzerland) Corporation Information
    • 12.2.2 Novartis International AG (Switzerland) Description and Business Overview
    • 12.2.3 Novartis International AG (Switzerland) Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 Novartis International AG (Switzerland) Pressurized Metered-dose Inhaler Products Offered
    • 12.2.5 Novartis International AG (Switzerland) Recent Development
  • 12.3 Propeller Health (USA)
    • 12.3.1 Propeller Health (USA) Corporation Information
    • 12.3.2 Propeller Health (USA) Description and Business Overview
    • 12.3.3 Propeller Health (USA) Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 Propeller Health (USA) Pressurized Metered-dose Inhaler Products Offered
    • 12.3.5 Propeller Health (USA) Recent Development
  • 12.4 AstraZeneca Plc (Sweden)
    • 12.4.1 AstraZeneca Plc (Sweden) Corporation Information
    • 12.4.2 AstraZeneca Plc (Sweden) Description and Business Overview
    • 12.4.3 AstraZeneca Plc (Sweden) Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 AstraZeneca Plc (Sweden) Pressurized Metered-dose Inhaler Products Offered
    • 12.4.5 AstraZeneca Plc (Sweden) Recent Development
  • 12.5 Philips Respironics (Netherlands)
    • 12.5.1 Philips Respironics (Netherlands) Corporation Information
    • 12.5.2 Philips Respironics (Netherlands) Description and Business Overview
    • 12.5.3 Philips Respironics (Netherlands) Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 Philips Respironics (Netherlands) Pressurized Metered-dose Inhaler Products Offered
    • 12.5.5 Philips Respironics (Netherlands) Recent Development
  • 12.6 Teva Pharmaceutical Industries （Israel）
    • 12.6.1 Teva Pharmaceutical Industries （Israel） Corporation Information
    • 12.6.2 Teva Pharmaceutical Industries （Israel） Description and Business Overview
    • 12.6.3 Teva Pharmaceutical Industries （Israel） Sales, Revenue and Gross Margin (2015-2020)
    • 12.6.4 Teva Pharmaceutical Industries （Israel） Pressurized Metered-dose Inhaler Products Offered
    • 12.6.5 Teva Pharmaceutical Industries （Israel） Recent Development
  • 12.7 Opko Health (USA)
    • 12.7.1 Opko Health (USA) Corporation Information
    • 12.7.2 Opko Health (USA) Description and Business Overview
    • 12.7.3 Opko Health (USA) Sales, Revenue and Gross Margin (2015-2020)
    • 12.7.4 Opko Health (USA) Pressurized Metered-dose Inhaler Products Offered
    • 12.7.5 Opko Health (USA) Recent Development
  • 12.8 Merck (USA)
    • 12.8.1 Merck (USA) Corporation Information
    • 12.8.2 Merck (USA) Description and Business Overview
    • 12.8.3 Merck (USA) Sales, Revenue and Gross Margin (2015-2020)
    • 12.8.4 Merck (USA) Pressurized Metered-dose Inhaler Products Offered
    • 12.8.5 Merck (USA) Recent Development
  • 12.9 BioCare Group （Malaysia）
    • 12.9.1 BioCare Group （Malaysia） Corporation Information
    • 12.9.2 BioCare Group （Malaysia） Description and Business Overview
    • 12.9.3 BioCare Group （Malaysia） Sales, Revenue and Gross Margin (2015-2020)
    • 12.9.4 BioCare Group （Malaysia） Pressurized Metered-dose Inhaler Products Offered
    • 12.9.5 BioCare Group （Malaysia） Recent Development
  • 12.11 Glenmark Pharmaceuticals (India)
    • 12.11.1 Glenmark Pharmaceuticals (India) Corporation Information
    • 12.11.2 Glenmark Pharmaceuticals (India) Description and Business Overview
    • 12.11.3 Glenmark Pharmaceuticals (India) Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 Glenmark Pharmaceuticals (India) Pressurized Metered-dose Inhaler Products Offered
    • 12.11.5 Glenmark Pharmaceuticals (India) Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Pressurized Metered-dose Inhaler Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Pressurized Metered-dose Inhaler Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Pressurized Metered-dose Inhaler market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Pressurized Metered-dose Inhaler market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Segment by Type, the Pressurized Metered-dose Inhaler market is segmented into
    Single-dose Inhalers
    Multi-dose Inhalers

    Segment by Application, the Pressurized Metered-dose Inhaler market is segmented into
    Hospitals
    Ambulatory Surgery Centres

    Regional and Country-level Analysis
    The Pressurized Metered-dose Inhaler market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Pressurized Metered-dose Inhaler market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

    Competitive Landscape and Pressurized Metered-dose Inhaler Market Share Analysis
    Pressurized Metered-dose Inhaler market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pressurized Metered-dose Inhaler business, the date to enter into the Pressurized Metered-dose Inhaler market, Pressurized Metered-dose Inhaler product introduction, recent developments, etc.
    The major vendors covered:
    Glenmark Pharmaceuticals (India)
    Novartis International AG (Switzerland)
    Propeller Health (USA)
    AstraZeneca Plc (Sweden)
    Philips Respironics (Netherlands)
    Teva Pharmaceutical Industries （Israel）
    Opko Health (USA)
    Merck (USA)
    BioCare Group （Malaysia）

    Buy now